Takeda Pharmaceutical Company Limited Key Management Personnel Compensation
Takeda Pharmaceutical Company Limited (TAK) reported Key Management Personnel Compensation of JPY 4.49 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:KeyManagementPersonnelCompensation · last filed 2025-06-25
| Period end | Key Management Personnel Compensation 12 month |
|---|---|
| 2025-03-31 | 4.49B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 4.67B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 4.08B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 4.20B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 4.19B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 4.63B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 3.60B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 2.53B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 2.46B JPY 20-F · filed 2019-06-27 |